Literature DB >> 3950901

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives.

W F Hoffman, A W Alberts, E J Cragoe, A A Deana, B E Evans, J L Gilfillan, N P Gould, J W Huff, F C Novello, J D Prugh.   

Abstract

A series of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic (heptanoic) acids and their lactone derivatives have been prepared and tested for inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vitro. A systematic exploration of the structure-activity relationships in this series led to the synthesis of (+)-trans-(E)-6-[2-[2,4-dichloro-6-[(4-fluorophenyl) methoxyl]phenyl]ethyl]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one (66(+)), which has one-half of the inhibitory activity of compactin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950901     DOI: 10.1021/jm00152a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Pharmacophore identification by molecular modeling and chemometrics: the case of HMG-CoA reductase inhibitors.

Authors:  U Cosentino; G Moro; D Pitea; S Scolastico; R Todeschini; C Scolastico
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

2.  Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4.

Authors:  W Kim; L Y Khil; R Clark; S H Bok; E E Kim; S Lee; H S Jun; J W Yoon
Journal:  Diabetologia       Date:  2006-08-09       Impact factor: 10.122

3.  Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction.

Authors:  Maria Elena Giusepponi; Carlo Cifani; Maria Vittoria Micioni Di Bonaventura; Laura Mattioli; Alan Hudson; Eleonora Diamanti; Fabio Del Bello; Mario Giannella; Valerio Mammoli; Corinne Dalila Paoletti; Alessandro Piergentili; Maria Pigini; Wilma Quaglia
Journal:  ACS Med Chem Lett       Date:  2016-09-08       Impact factor: 4.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.